Cytokines as Biomarkers of Treatment Response to IFNβ in Relapsing-Remitting Multiple Sclerosis

Table 2

Data of study subjects.

Patients (𝑛)	43
Female/male (𝑛)	25/18
Age at diagnosis (years)	33.26 ± 9.88
Disease duration (years)	2.22 ± 3.35
EDSS acute	2.72 ± 0.95
EDSS remission	1.93 ± 0.96
EDSS final	2.66 ± 1.90
ARR (total)	0.43 ± 0.56
Follow-up duration (years)	5.31 ± 1.58
IgG index	1.02 ± 0.62
T2 lesions (baseline)	10.51 ± 5.52
T1 Gd+ lesions (baseline)	2.16 ± 2.12
CSF cell number (per 𝜇L)	9.72 ± 8.29

Data are presented as mean ± SD; T1 Gd+: gadolinium enhancing lesions.